Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR8943008

e150d30e-622c-5bd8-a716-1484f30efb1e

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • BILE_ACID_METABOLISM+0.150
  • NOTCH_SIGNALING+0.040
  • PEROXISOME+0.040
  • TGF_BETA_SIGNALING+0.010
  • WNT_BETA_CATENIN_SIGNALING+0.010
  • MYC_TARGETS_V2-0.020
  • PROTEIN_SECRETION-0.050
  • KRAS_SIGNALING_DN-0.090
  • PANCREAS_BETA_CELLS-0.090
  • XENOBIOTIC_METABOLISM-0.090

Top 10 suppressed

  • E2F_TARGETS-0.570
  • G2M_CHECKPOINT-0.550
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.510
  • ANGIOGENESIS-0.490
  • CHOLESTEROL_HOMEOSTASIS-0.450
  • IL6_JAK_STAT3_SIGNALING-0.440
  • INTERFERON_ALPHA_RESPONSE-0.430
  • INTERFERON_GAMMA_RESPONSE-0.410
  • INFLAMMATORY_RESPONSE-0.360
  • MTORC1_SIGNALING-0.360

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

9 twins match this tumor's tissue · 1 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1C3N-03420
lung-landscapes@6
cohortA10.929
2R247
bladder-landscape@3
0.925
3TCGA-CF-A5U8-01A-11R-A28M-07
bladder-landscape@3
0.911
4TCGA-LT-A8JT-01A-11R-A36F-07
bladder-landscape@3
0.909
5TCGA-CF-A27C-01A-11R-A16R-07
bladder-landscape@3
0.903
6EPT0291
medullo-epn-umap@date-based
EPNEPN Tumor0.896
7SRR8613727
breast-umap@18
D0.894
8SRR8942980
bladder-landscape@3
0.893
9TCGA-FD-A43X-01A-11R-A23W-07
bladder-landscape@3
0.892
10MBCProject_0004_T1_RNA
breast-umap@18
C0.890

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 5 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
BILE_ACID_METABOLISM0.150Inavolisib— uncovered
NOTCH_SIGNALING0.040Inavolisib— uncovered
PEROXISOME0.040Idelalisib— uncovered
TGF_BETA_SIGNALING0.010Inavolisib— uncovered
WNT_BETA_CATENIN_SIGNALING0.010Inavolisib— uncovered